Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline in the treatment of schizophrenia
IRCT201202241556N34Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of minocycline in schizophrenia, sponsored by Tehran University of Medical Sciences. Started Mar 2012; status: completed.
02
Drugs
minocycline
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT201202241556N34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201202241556N34.